Company intelligence / Profile preview

Hello Daisy

Auckland, Auckland Region, New Zealandshophellodaisy.com ↗

Ownership: Private
Development stage: Other

Overview

Daisy Lab has developed yeast strains capable of producing cow’s milk proteins such as beta-lactoglobulin and lactoferrin using precision fermentation. The company has received regulatory approval to scale up its GMO fermentations to 5000L in New Zealand, enabling pilot plant development. They are currently raising pre-Series A funding to build this pilot facility. No clinical results apply as their products are intended for food use rather than therapeutics.

Therapeutic areas: Gastroenterology
Modalities: ProteinRecombinant proteinPrecision fermentation-derived protein
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships reported; focus appears to be on local innovation ecosystem in New Zealand.

Beyond the preview

Go deeper on Hello Daisy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hello Daisy.

Explore the full profile